Relationships between distribution of lead in erythrocytes in vivo and in vitro and inhibition of ALA-D.
AUTOR(ES)
Sakai, T
RESUMO
Proteins in the ALA-D (delta-aminolaevulinic acid dehydratase) fraction from gel filtration of erythrocyte supernatant (ES) have the highest affinity for lead among erythrocyte constituents in vivo and in vitro. It takes 20-40 hours for erythrocyte components to be equilibrated with lead added in vitro. AT low lead concentrations, under 60 micrograms/100 ml ES, the extent of decrease in ALA-D activity indicates the extent of lead saturation of ALA-D fraction proteins. The saturation is attained at 80-110 micrograms/100 ml ES. Although an appreciable amount of lead is also found in the haemoglobin fraction that contains certain factors concerned in ALA-D inhibition, lead responsible for inducing the inhibition is not bound to haemoglobin fraction proteins but to ALA-D fraction proteins. Of three treatments or agents recovering the enzyme from lead effects, zinc is the only one that can fully restore the inhibition.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1009070Documentos Relacionados
- Erythrocyte factors concerned in the inhibition of ALA-D by lead.
- Mechanisms of ALA-D inhibition by lead and of its restoration by zinc and dithiothreitol.
- Lead and zinc concentrations in plasma, erythrocytes, and urine in relation to ALA-D activity after intravenous infusion of Ca-EDTA.
- Interrelationships between lead in blood, lead in urine, and ALA in urine during lead work
- Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.